✓ Purity · pass✓ Lab-verifiedShop-provided sample
Tesamorelin + Ipamorelin × s1research.net — lab test, July 2026
Tested · submitted by Peptigrity Team Member 02PEPTIGRITY TEAM
Sample source: shop-provided. The shop chose and sent this vial. Samples bought at retail by a member carry more weight.How we weigh evidence →
HPLC Purity
99.72%
✓ Excellent purity only
Independently confirmed on the lab’s portal✓ Extra check
COA 2607280142 matches freedomdiagnosticstesting.com's public record. So this test doesn't rest on our review alone — the lab confirms it too.
Lookup code
Step2607280142Look it up on freedomdiagnosticstesting.com ↗Checked Jul 31, 2026
Test results
6 data points
Purity
99.72%
Endotoxins
Pass (≤0.05 EU/mL)
Heavy metals
Pass — Arsenic, Cadmium, Lead, and Mercury below reporting/specification limits
Stated qty
Not provided
Tested qty
Not provided
Batch / Lot
TIG62526
COA number
2607280142
Container
White Lyophilized Powder
Tested by
freedomdiagnosticstesting.comView profile →
About this test
Verification trail
| Report number | 2607280142 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 3 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | freedomdiagnosticstesting.com's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tesamorelin + Ipamorelin from s1research.net, performed by freedomdiagnosticstesting.com on July 31, 2026. Reported purity: 99.72%. Endotoxins: Pass (≤0.05 EU/mL). Heavy metals: Pass — Arsenic, Cadmium, Lead, and Mercury below reporting/specification limits. Batch TIG62526. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Original document
Issued by freedomdiagnosticstesting.com · Jul 31, 2026 · Batch TIG62526
♡ Likes · 0
No comments yet. Sign in to discuss this test →
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion